University Of Turku
- Address
- P. O. Box 52
Sponsor Overview
Specializations
Progressive multiple sclerosis
The clinical research activity is centered on progressive multiple sclerosis, with attention to smoldering inflammation and disease-related changes within the central nervous system. The focus includes inflammatory activity in cerebral white matter and the biological processes associated with ongoing neurological decline.
- Multiple sclerosis
- Progressive disease
- Neuroinflammation
- White matter pathology
Research activity in this area is linked to imaging-based assessment of inflammatory burden in the brain, supporting investigation of disease mechanisms in patients with progressive forms of MS.
Neuroimaging and brain inflammation
The sponsor’s trial portfolio includes positron emission tomography approaches used to examine inflammatory activity in the brain, with emphasis on TSPO-PET imaging and voxel-level changes in cerebral tissue. This area reflects interest in mapping inflammatory signals within white matter while excluding established lesion regions.
- TSPO-PET
- Positron emission tomography
- Cerebral white matter
- Voxel-based imaging
The imaging focus supports detailed evaluation of inflammatory activity in relation to progressive neurological disease.
Neurology and therapeutic modulation
Clinical interest extends to neurology with a therapeutic emphasis on modifying inflammatory pathways relevant to demyelinating disease. The funded research explores treatment effects in patients with progressive neurological impairment, highlighting interest in interventions aimed at reducing ongoing inflammatory activity.
- Neurological disease
- Demyelination
- Inflammatory modulation
- Disability progression
This therapeutic domain is closely tied to the search for disease-relevant biological changes that may be measurable in the brain.
Clinical neuroscience
The sponsor’s research landscape sits within clinical neuroscience, combining disease-focused brain imaging with therapeutic evaluation in a progressive neurological condition. The work involves collaboration across multiple research sites in Finland, supporting clinical investigation in a specialized academic setting.
- Clinical neuroscience
- Academic medicine
- Multisite collaboration
- Neurological inflammation
The main medical interest remains centered on understanding and measuring inflammatory disease activity in progressive MS.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Istradefylline for Reducing Microglial Activation in Progressive Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial |  Finland | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 3 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases1 trial322 other sponsors
- 2.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
3 centres- Address
- Itainen Pitkakatu 4b, 20520 Turku
- Address
- Kiinamyllynkatu 4-8, 20520 Turku
Want to get in touch with this sponsor?
Send a question and we'll pass it on to University Of Turku.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.